康希诺:2024年净利润亏损3.79亿元

澎湃新闻
Feb 27, 2025

2月27日,康希诺生物股份公司发布业绩快报,2024年公司实现营业收入8.46亿元,同比增加137.01%;实现归属于母公司所有者的净利润亏损3.79亿元,上年同期亏损14.82亿元。报告期内。公司持续搭建销售渠道ACYW135群脑膜炎球菌多糖结合疫苗(CRM197 载体)曼海欣®作为中国市场上唯一的四价流脑结合疫苗,市场占有率不断提升,同时公司经营受全球公共卫生事件的影响已经基本消除。因此,公司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10